Title

The Potential Benefits of Research May Justify Certain Research Risks.

Document Type

Article

Publication Date

3-2019

Identifier

DOI: 10.1542/peds.2018-1703

Abstract

US regulations allow institutional review boards to approve pediatric clinical trials only when the risks are minimal or (in some cases) a minor increase over minimal, or when the risks are justified by a potential for direct benefit to the participants. But how should an institutional review board determine if the risks of pediatric clinical trials are justified by a potential for participant benefit? In this Ethics Rounds article, we consider which potential benefits can justify which research risks with a focus on randomized clinical trials.

Journal Title

Pediatrics

Volume

143

Issue

3

MeSH Keywords

Administration, Intravenous; Biliary Atresia; Biomedical Research; Child; Ethics Committees, Research; Glucocorticoids; Humans; Methylprednisolone; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment

Keywords

Administration, Intravenous; Biliary Atresia; Biomedical Research; Child; Ethics Committees, Research; Glucocorticoids; Humans; Methylprednisolone; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment

Share

COinS